Researchers at the University of Michigan are uncovering how the gut and pancreatic microbiomes may influence the way patients respond to pancreatic cancer treatment. Assistant professor Donnele Daley explains why certain bacteria and fungi appear more often in pancreatic tumors and how these microbes may shape immune responses or even metabolize chemotherapy drugs. The full story highlights emerging research and shows why clinical trials that collect microbiome samples could help scientists develop new treatment approaches.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.